drugset / Trial / NCT01035021

Neuromuscular Block in Laryngeal Mask Airway(LMA) Insertion

NCT01035021

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of this study is to evaluate the success rate, insertion time and complication depending on the use of neuromuscular blocking agent when inserting the laryngeal mask airway (LMA).

Timeline

Start
2009-06
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rocuronium Other / unclassified 0.06 mg/kg Other

Indications